As Canada makes moves to legalize and regulate recreational marijuana from production to consumption, the industry has quickly become more high-skill and high-tech, with investments to mirror the growth. However, prior to receiving regulatory approvals, cannabis products, like any supplement, must undergo the rigorous claims substantiation.
Scientists at KGK Science are leading research on CBD for the supplement industry in North America, partnering with critical stakeholders in the design of gold-standard randomized double-blind placebo-controlled studies. Available research suggests the phyto-cannabinoid preparations interact with the endocannabinoid system, regulating energy metabolism, hemodynamic changes, inflammation, weight loss, anxiety and cognition. Rigorous and adequately powered study designs addressing several crucial aspects in research design are warranted to establish the evidence-base for CBD in the supplement industry.